Skip to main content

Stigmabase | HIV

Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

| |

Nika Pharmaceuticals, Inc. (NIKA) Markets Analysis and €8.5 Billion Projected Revenue

South Africa Time — Tuesday, May 20, 2025

New market analysis reveals Nika's HIV treatment distribution reach across Nigeria, Ukraine, and MENA region. See country-specific revenue ...

View article...

Racial Xperience

Top stories of the last 30 days

HIV pill improves diabetic eye disease without injections

South Africa Time — Wednesday, May 28, 2025

An inexpensive pill for treating HIV could become an alternative to injections for diabetic eye disease, a small study suggests. View article...

Advocates fear federal funding cuts to HIV/AIDS prevention programs

South Africa Time — Thursday, May 08, 2025

Advocates on the front lines of HIV /AIDS prevention say federal funding cuts could mean a dangerous slide back in the fight against the epidemic. View article...

Machine Learning Capable of Predicting Hyperlipidemia in People With HIV

South Africa Time — Wednesday, May 28, 2025

People living with HIV who have taken highly active antiretroviral therapy can have hyperlipidemia predicted in advance by machine learning. View article...

More than 40 per cent of HIV-focused charities have had to reduce staff over past three years

South Africa Time — Friday, May 30, 2025

... HIV action plans, multi-year funding agreements that cover core costs to ensure the sustainability of essential HIV services, and expanded ... View article...

Gilead pays partner Hookipa $10M for HBV, HIV vaccines

South Africa Time — Friday, May 23, 2025

Gilead is paying $10 million for sole ownership of arenaviral immunotherapies for hepatitis B and HIV . View article...

China, UNAIDS to help Iran boost HIV rapid response

South Africa Time — Wednesday, May 14, 2025

In an effort to enhance the overall resilience of Iran's national AIDS program and HIV testing capacity, Iran's Health Ministry, ... View article...

Neuropsychiatric adverse events in people with HIV initiating a new integrase strand transfer ...

South Africa Time — Wednesday, May 28, 2025

(CNS)/neuropsychiatric (NP) disturbances among people with HIV (PWH) receiving integrase strand transfer inhibitors (INSTI) or other antiretroviral View article...

Incidence and risk factors for tuberculosis at a rural HIV clinic in Uganda, 2012–2019

South Africa Time — Friday, May 23, 2025

Tuberculosis (TB) is the leading cause of death among people living with HIV (PLHIV). Antiretroviral therapy (ART) initiation lowers the risk of ... View article...

JOHANNESBURG

Stigmabase is a canadian non-profit internet initiative dedicated to informing and raising awareness on the damaging effects of social exclusion and stigma around the world. The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

Powered by Blogger

2010 - 2025 ― Stigmabase Global Initiative || Keeping up-to-date on global exclusion

Top stories of the last 7 days

More than 40 per cent of HIV-focused charities have had to reduce staff over past three years

South Africa Time — Friday, May 30, 2025

... HIV action plans, multi-year funding agreements that cover core costs to ensure the sustainability of essential HIV services, and expanded ... View article...

The road to lenacapavir, a breakthrough HIV treatment

South Africa Time — Friday, May 30, 2025

... antiretroviral therapy—worked well, it required daily medication. A dedicated group of scientists at Gilead Sciences showed perseverance as it ... View article...

Giving LGBTQ Youth the Tools to Fight HIV

South Africa Time — Tuesday, June 03, 2025

Queer youth also have a higher incidence of HIV . According to the Centers for Disease Control and Prevention (CDC), in 2021, 19% of new HIV cases were ... View article...

Exposure to Certain HIV Drugs May Significantly Lower Risk for Alzheimer Disease

South Africa Time — Tuesday, June 03, 2025

Exposure to nucleoside reverse transcriptase inhibitors (NRTIs), which treat HIV and hepatitis B and inhibit inflammasome activation, ... View article...

HIV, Queer Identity and the Politics of Health Care

South Africa Time — Tuesday, June 03, 2025

Since the dawn of the AIDS crisis, HIV has disproportionately affected LGBTQ people. Even though science and statistics have proved that no group ... View article...

An Update on PEPFAR Reauthorization

South Africa Time — Friday, May 30, 2025

PEPFAR, the U.S. President's Emergency Plan for AIDS Relief, is the U.S. government's signature global health effort in the fight against HIV . View article...

Number of those diagnosed with HIV continuing to decrease

South Africa Time — Friday, May 30, 2025

The majority (87%) had an undetectable viral load, indicating they were on antiretroviral therapy and could not pass HIV on sexually. People ... View article...

Virological treatment failure and associated factors among adults on first-line antiretroviral ...

South Africa Time — Tuesday, June 03, 2025

BackgroundVirological failure on first-line antiretroviral therapy (ART) remains a major challenge in the management of HIV/AIDS in ... View article...

ABOUT STIGMABASE
Request for Review

Total Pageviews